Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS

Journal of Neurochemistry

Volumn 115, Issue 5, 2010, Pages 1102-1111

  Ezzi, Samer Abou ^a   Larivière, Roxanne ^a   Urushitani, Makoto ^b   Julien, Jean Pierre ^a  

^a Université Laval   (Canada)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Chromogranins; Degeneration; Motor neuron; Mutant SOD1; Transgenic mice

Indexed keywords

CHROMOGRANIN A; COPPER ZINC SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; FEMALE; MALE; MOTOR DYSFUNCTION; MOTOR NERVE; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

EID: 78149251540     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06979.x     Document Type: Article

References (29)

1. Barneoud P. and Curet O. (1999) Beneficial effects of lysine acetylsalicylate, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis. Exp. Neurol. 155, 243-251.
2. Beaulieu J. M., Nguyen M. D. and Julien J. P. (1999) Late onset of motor neurons in mice overexpressing wild-type peripherin. J. Cell Biol. 147, 531-544.
3. Beers D. R., Henkel J. S., Xiao Q., Zhao W., Wang J., Yen A. A., Siklos L., McKercher S. R. and Appel S. H. (2006) Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 103, 16021-16026.
4. Boillee S., Yamanaka K., Lobsiger C. S., Copeland N. G., Jenkins N. A., Kassiotis G., Kollias G. and Cleveland D. W. (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389-1392.
5. Ciesielski-Treska J., Ulrich G., Taupenot L., Chasserot-Golaz S., Corti A., Aunis D. and Bader M. F. (1998) Chromogranin A induces a neurotoxic phenotype in brain microglial cells. J. Biol. Chem. 273, 14339-14346.
6. Couse J. F., Davis V. L., Tally W. C. and Korach K. S. (1994) An improved method of genomic DNA extraction for screening transgenic mice. BioTechniques 17, 1030-1032.
7. Fiesel F. C., Voigt A., Weber S. S. et al. (2010) Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J. 29, 209-221.
8. Gowing G., Philips T., Van Wijmeersch B., Audet J. N., Dewil M., Van Den Bosch L., Billiau A. D., Robberecht W. and Julien J. P. (2008) Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase. J. Neurosci. 28, 10234-10244.
9. Gros-Louis F., Andersen P. M., Dupre N. et al. (2009) Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 106, 21777-21782.
10. Gros-Louis F., Soucy G., Lariviere R. and Julien J. P. (2010) Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. J. Neurochem. 113, 1188-1199.
11. Gurney M. E. (1994) Transgenic-mouse model of amyotrophic lateral sclerosis. N. Engl. J. Med. 331, 1721-1722.
12. Gurney M. E., Cutting F. B., Zhai P., Doble A., Taylor C. P., Andrus P. K. and Hall E. D. (1996) Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39, 147-157.
13. Helle K. B. (2004) The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects. Biol. Rev. Camb. Philos. Soc. 79, 769-794.
14. Kingham P. J., Cuzner M. L. and Pocock J. M. (1999) Apoptotic pathways mobilized in microglia and neurones as a consequence of chromogranin A-induced microglial activation. J. Neurochem. 73, 538-547.
15. Laflamme N., Lacroix S. and Rivest S. (1999) An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J. Neurosci. 19, 10923-10930.
16. Lobsiger C. S., Boillee S., McAlonis-Downes M., Khan A. M., Feltri M. L., Yamanaka K. and Cleveland D. W. (2009) Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Proc. Natl Acad. Sci. USA 106, 4465-4470.
17. Marksteiner J., Lechner T., Kaufmann W. A., Gurka P., Humpel C., Nowakowski C., Maier H. and Jellinger K. A. (2000) Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer's disease. Acta Neuropathol. 100, 205-212.
18. Nguyen M. D., Lariviere R. C. and Julien J. P. (2001) Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30, 135-147.
19. Nishimura M., Tomimoto H., Suenaga T., Nakamura S., Namba Y., Ikeda K., Akiguchi I. and Kimura J. (1994) Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains. Brain Res. 634, 339-344.
20. Rangon C. M., Haik S., Faucheux B. A., Metz-Boutigue M. H., Fierville F., Fuchs J. P., Hauw J. J. and Aunis D. (2003) Different chromogranin immunoreactivity between prion and a-beta amyloid plaque. Neuroreport 14, 755-758.
21. Rosen D. R., Siddique T., Patterson D. et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62.
22. Schiffer D., Cordera S., Giordana M. T., Attanasio A. and Pezzulo T. (1995) Synaptic vesicle proteins, synaptophysin and chromogranin A in amyotrophic lateral sclerosis. J. Neurol. Sci. 129(Suppl), 68-74.
23. Schrott-Fischer A., Bitsche M., Humpel C., Walcher C., Maier H., Jellinger K., Rabl W., Glueckert R. and Marksteiner J. (2009) Chromogranin peptides in amyotrophic lateral sclerosis. Regul. Pept. 152, 13-21.
24. Taupenot L., Harper K. L. and O'Connor D. T. (2003) The chromogranin-secretogranin family. N. Engl. J. Med. 348, 1134-1149.
25. Urushitani M., Sik A., Sakurai T., Nukina N., Takahashi R. and Julien J. P. (2006) Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 9, 108-118.
26. Urushitani M., Ezzi S. A. and Julien J. P. (2007) Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 104, 2495-2500.
27. Urushitani M., Ezzi S. A., Matsuo A., Tooyama I. and Julien J. P. (2008) The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS. FASEB J. 22, 2476-2487.
28. Yamanaka K., Chun S. J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D. H., Takahashi R., Misawa H. and Cleveland D. W. (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11, 251-253.
29. Zhao W., Beers D. R., Henkel J. S., Zhang W., Urushitani M., Julien J. P. and Appel S. H. (2009) Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia 58, 231-243.